CytRx Corporation (CYTR) - NASDAQ
From other sites
Company Description
CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. The company on the clinical development of aldoxorubicin oncology pipeline for the treatment of cancer. CytRx was founded on February 28, 1985 and is headquartered in Los Angeles, CA.
Sector: Healthcare
Industry: Biotechnology
Country: United States